Lithuania - Diabetes Medicine Use
Since 2014, Lithuania Diabetes Medicine Use grew 4.4% year on year. In 2019, the country was number 24 comparing other countries in Diabetes Medicine Use with 54.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Lithuania is overtaken by Australia, which was number 23 at 58 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Iceland with 48.8 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Finland lead the ranking with 97.3 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, an increase of 1.6% compared to 2018. Czech Republic, Canada and United Kingdom respectively ranked number 2, 3 and 4 in this ranking. Canada witnessed the best average annual growth at +9.6% per year, while Chile witnessed the worst performance at -1.6% per year.
Loading...
| Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
|---|---|
| 2019 | 54.30 |
| 2018 | 53.60 |
| 2017 | 50.00 |
| 2016 | 47.80 |
| 2015 | 44.30 |
How does Lithuania rank in Diabetes Medicine Use?
| # | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Finland
|
97 | 2019 | +1.6 % | +2.0 % | View data | |
| 2 |
#2
Czech Republic
|
93 | 2019 | +2.8 % | +1.9 % | View data | |
| 23 |
#23
Australia
|
58 | 2019 | +0.7 % | +0.2 % | View data | |
| 24 |
#24
Lithuania
|
54 | 2019 | +1.3 % | +4.4 % | View data | |
| 25 |
#25
Iceland
|
49 | 2019 | +0.4 % | +2.8 % | View data | |